HarrietOliviaSmithMD

Obstetrics & Gynecology • Bronx, NY

General Gynecology, Gynecologic Oncology, Urogynecology & Pelvic Reconstructive Surgery

Professor of Obsetrics and Gynecology, Chief of Gyn Oncology BronxCare Bronx Ny

Join to view full profile

Dr. Smith is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Smith's full profile

Already have an account?

Office
1650 Grand Concourse 5th floor Ob/gyn
Bronx Ny
Bronx, NY 10457
Phone+1 718-579-3953

Fax+1 718-239-8630
Is this information wrong?

Summary

Dr. Harriet Smith is an obstetrician/gynecologist in Bronx, NY and is affiliated with multiple hospitals in the area, including NYC Health + Hospitals / Jacobi, BronxCare Health System, NYC Health + Hospitals / North Central Bronx, Montefiore Medical Center, St. Barnabas Hospital, and NYC Health + Hospitals / Coney Island. She received her medical degree from Medical College of Georgia School of Medicine and has been in practice 37 years. She specializes in general gynecology and gynecologic oncology and is experienced in general gynecology, gynecologic oncology, cytokines, gpr30, and spectroscopy.

Education & Training

Montefiore Medical Center/Albert Einstein College of MedicineFellowship, Gynecologic Oncology, 1989 - 1990
Emory University School of MedicineFellowship, Female Pelvic Medicine And Reconstructive Surgery (Obgyn), 1988 - 1989
University of Texas Health Science Center at HoustonResidency, Obstetrics and Gynecology, 1987 - 1988
Emory University School of MedicineResidency, Obstetrics and Gynecology, 1982 - 1986
Medical College of GeorgiaResidency, Family Medicine, 1981 - 1982
Medical College of GeorgiaResidency, Obstetrics and Gynecology, 1981 - 1981
Medical College of Georgia at Augusta UniversityClass of 1980

Certifications & Licensure

NY State Medical License 1991 - 2025
NM State Medical License 1988 - 2013
GA State Medical License 1982 - 1991
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

Top Doctors: New York Metro Area Castle Connolly, 2009-2014
America's Top Doctors Castle Connolly, 2003-2008
America's Top Doctors for Cancer Castle Connolly, 2005-2007
Top Doctors in Gynecologic Oncology Castle Connelly
Presidents Award, Society of Gynecologic Oncologists Society of Gynecologic Oncologists
Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Join now to see all

Clinical Trials

S9717 Tirapazamine Plus Cisplatin in Treating Patients With Metastatic, Recurrent, or Refractory Cervical Cancer Start of enrollment: 1998 Aug 01
Completed
Phase 2
S9912 Combination Chemo in Stage III Ovarian Cancer, Start of enrollment: 1999 Sep 01
Completed
Phase 2
Non-Invasive, Real-Time Technology for Diagnosis of Cervical Tissue Start of enrollment: 2004 Apr 01
Terminated
Not Applicable
Colony-Stimulating Factor-1 (CSF-1) and Other Cytokines in Human Endometrial Carcinogenesis Start of enrollment: 1998 Jan 01
Withdrawn
Pre-Clinical Models in Gynecological Tumors A Tissue Repository Start of enrollment: 2002 Jul 01
Completed
Scheduled Triple-lumen Central Venous Catheter Exchange: A Prospective Controlled Randomized Study Start of enrollment: 1994 Mar 01
Terminated
Not Applicable
Study of Adjuvant Topotecan and Cisplatin With Concurrent Radiation Therapy for Advanced Cervical Cancer Start of enrollment: 2002 Mar 01
Completed
Phase 1
SGO Society of Gynecologic Oncologists Data Outcomes Project Start of enrollment: 2002 Mar 01
Terminated
Differences in Trends Malignant Germ Cell Tumors in Males and Females: A SEER Population-based Study Start of enrollment: 2006 Jan 01
Withdrawn
Trends in Incidence and Survivals for Ovarian Germ Cell Tumors: A 27-Year Population-Based Study Start of enrollment: 2005 Dec 01
Withdrawn
Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer Start of enrollment: 2009 Jan 16
Terminated
Phase 2
Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer Start of enrollment: 2011 Jul 08
Terminated
Not Applicable
Join now to see all

Publications & Presentations

PubMed

4 citations
Utility of a custom designed next generation DNA sequencing gene panel to molecularly classify endometrial cancers according to The Cancer Genome Atlas subgroups.
E.M. Miller, Nicole E. Patterson, Gregory M. Gressel, Rouzan G. Karabakhtsian, Michal Bejerano-Sagie, Nivedita Ravi, Alexander Y. Maslov, Wilber Quispe-Tintaya, Tao Wa...> ;BMC Medical Genomics. 2020 Nov 30
488 citations
Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets.
Luca Cassetta, Stamatina Fragkogianni, Andrew H. Sims, Agnieszka Swierczak, Lesley M. Forrester, Hui Zhang, Daniel Y.H. Soong, Tiziana Cotechini, Pavana Anur, Elaine Y...> ;Cancer Cell. 2019 Apr 15
9 citations
Adjuvant Pelvic Radiation "Sandwiched" Between Paclitaxel/Carboplatin Chemotherapy in Women With Completely Resected Uterine Serous Carcinoma: Long-term Follow-up of a...
Marina Frimer, Eirwen M. Miller, Viswanathan Shankar, Eugenia Girda, Keyur J. Mehta, Harriet O. Smith, Dennis Yi-Shin Kuo, Gary L. Goldberg, Mark H. Einstein> ;International Journal of Gynecological Cancer. 2018 Nov 1
45 citations
Isolation of Mouse and Human Tumor-Associated Macrophages
Luca Cassetta, Roy Noy, Agnieszka Swierczak, Gaël Sugano, Harriet O. Smith, Lisa Wiechmann, Jeffrey W. Pollard> ;Advances in Experimental Medicine and Biology. 2016 Jan 1
7 citations
Hemoglobin parameters from diffuse reflectance data
Judith R. Mourant, Oana C. Marina, Tiffany Hebert, Gurpreet Kaur, Harriet O. Smith> ;Journal of Biomedical Optics. 2014 Mar 1
121 citations
G Protein-Coupled Estrogen Receptor-Selective Ligands Modulate Endometrial Tumor Growth
Whitney K. Petrie, Megan K. Dennis, Chelin Hu, Donghai Dai, Jeffrey B. Arterburn, Harriet O. Smith, Helen J. Hathaway, Eric R. Prossnitz> ;Obstetrics and Gynecology International. 2013 Nov 27
43 citations
The clinical significance of inflammatory cytokines in primary cell culture in endometrial carcinoma
Harriet O. Smith, Nicole D. Stephens, Clifford Qualls, Tal Fligelman, Tao Wang, Chang-Yun Lin, Elizabeth Burton, Jeffrey Griffith, Jeffrey W. Pollard> ;Molecular Oncology. 2013 Feb 1
15 citations
High prevalence of high grade anal intraepithelial neoplasia in HIV-infected women screened for anal cancer
June Y. Hou, David Smotkin, Robert Grossberg, Mark J. Suhrland, Rebecca Levine, Harriet O. Smith, Abdissa Negassa, Thomas McAndrew, Mark H. Einstein> ;Journal of Acquired Immune Deficiency Syndromes. 2012 Jun 1
12 citations
Risk factors for poor prognosis in microinvasive adenocarcinoma of the uterine cervix (IA1 and IA2): a pooled analysis.
June Hou, Gary L. Goldberg, Clifford Qualls, Dennis Yi-Shin Kuo, Aliza Forman, Harriet O. Smith> ;Gynecologic Oncology. 2011 Apr 1
30 citations
Co-expression of GPR30 and ERβ and their association with disease progression in uterine carcinosarcoma
Gloria S. Huang, Marc J. Gunter, Rebecca C. Arend, Maomi Li, Hugo Arias-Pulido, Eric R. Prossnitz, Gary L. Goldberg, Harriet O. Smith> ;American Journal of Obstetrics and Gynecology. 2010 Sep 1
12 citations
A phase I study of flavopiridol in combination with gemcitabine and irinotecan in patients with metastatic cancer.
Houman M. Fekrazad, Claire F. Verschraegen, Melanie Royce, Harriet O. Smith, Fa-Chyi Lee, Ian Rabinowitz> ;American Journal of Clinical Oncology. 2010 Aug 1
72 citations
Insulin-like Growth Factor 2 Expression Modulates Taxol Resistance and Is a Candidate Biomarker for Reduced Disease-Free Survival in Ovarian Cancer
Gloria S. Huang, Jurriaan Brouwer-Visser, Marissa J. Ramirez, C. Kim, Tiffany Hebert, Juan Lin, Hugo Arias-Pulido, Clifford Qualls, Eric R. Prossnitz, Gary L. Goldberg...> ;Clinical Cancer Research. 2010 Jun 1
11 citations
Detection of cervical intraepithelial neoplasias and cancers in cervical tissue by in vivo light scattering.
Judith R. Mourant, Tamara M. Powers, Heather M. Greene, Maxine H. Dorin, Alan G. Waxman, Meggan M. Zsemlye, Harriet O. Smith> ;Journal of Lower Genital Tract Disease. 2009 Oct 1
171 citations
GPR30 predicts poor survival for ovarian cancer
Harriet O. Smith, Hugo Arias-Pulido, Dennis Yi-Shin Kuo, Tamara Howard, Clifford Qualls, Sang Joon Lee, Claire F. Verschraegen, Helen J. Hathaway, Nancy E. Joste, Eric...> ;Gynecologic Oncology. 2009 Sep 1
35 citations
Estrogen and progesterone receptor status and outcome in epithelial ovarian cancers and low malignant potential tumors.
Hugo Arias-Pulido, Harriet O. Smith, Nancy E. Joste, Clifford Qualls, Allison Chavez, Eric R. Prossnitz, Claire F. Verschraegen> ;Gynecologic Oncology. 2009 Sep 1
9 citations
Southwest Oncology Group Trial S9912: intraperitoneal cisplatin and paclitaxel plus intravenous paclitaxel and pegylated liposomal doxorubicin as primary chemotherapy ...
Harriet O. Smith, James Moon, Sharon P. Wilczynski, Amy Tiersten, Edward V. Hannigan, William R. Robinson, Saul E. Rivkin, Garnet L. Anderson, Poching Liu, Maurie Markman> ;Gynecologic Oncology. 2009 Aug 1
1 citations
Phase I study of capecitabine in combination with cisplatin and irinotecan in patients with advanced solid malignancies
Hamid Sayar, Zhiyuan Shen, Sang Joon Lee, Melanie Royce, Ian Rabinowitz, Fa-Chyi Lee, Harriet O. Smith, Steven C. Eberhardt, Adrian Maestas, H. Lu, Claire F. Verschraegen> ;Investigational New Drugs. 2009 Apr 1
19 citations
In vivo light scattering for the detection of cancerous and precancerous lesions of the cervix
Judith R. Mourant, Tamara M. Powers, Heather M. Greene, Maxine H. Dorin, Alan G. Waxman, Meggan M. Zsemlye, Harriet O. Smith> ;Applied Optics. 2009 Apr 1
26 citations
Phase II Evaluation of Neoadjuvant Chemotherapy and Debulking Followed by Intraperitoneal Chemotherapy in Women with Stage III and IV Epithelial Ovarian, Fallopian Tub...
Amy Tiersten, Poching Liu, Harriet O. Smith, Sharon P. Wilczynski, William R. Robinson, Maurie Markman, David S. Alberts> ;Gynecologic Oncology. 2009 Mar 1
6 citations
Chemotherapy resistance as a predictor of progression-free survival in ovarian cancer patients treated with neoadjuvant chemotherapy and surgical cytoreduction followe...
Amy Tiersten, James Moon, Harriet O. Smith, Sharon P. Wilczynski, William R. Robinson, Maurie Markman, David S. Alberts> ;Oncology. 2009 Jan 1
33 citations
Absence of epidermal growth factor receptor mutations in cervical cancer
Hugo Arias-Pulido, Nancy E. Joste, A. Chavez, Carolyn Y. Muller, Donghai Dai, Harriet O. Smith, Claire F. Verschraegen> ;International Journal of Gynecological Cancer. 2008 Jul 1
470 citations
Estrogen Signaling through the Transmembrane G Protein–Coupled Receptor GPR30
Eric R. Prossnitz, Jeffrey B. Arterburn, Harriet O. Smith, Tudor I. Oprea, Larry A. Sklar, Helen J. Hathaway> ;Annual Review of Physiology. 2008 Feb 13
39 citations
In vivo light scattering measurements for detection of precancerous conditions of the cervix
Judith R. Mourant, Tamara M. Powers, Heather M. Greene, Kathy L. Bullock, Lisa R. Marr-Lyon, Maxine H. Dorin, Alan G. Waxman, Meggan M. Zsemlye, Harriet O. Smith> ;Gynecologic Oncology. 2007 May 1
187 citations
GPR30: a novel indicator of poor survival for endometrial carcinoma.
Harriet O. Smith, Kimberly K. Leslie, Meenakshi Singh, Clifford Qualls, Chetana M. Revankar, Nancy E. Joste, Eric R. Prossnitz> ;American Journal of Obstetrics and Gynecology. 2007 Apr 1
9 citations
Changing trends in gestational trophoblastic disease.
Harriet O. Smith, Charles L. Wiggins, Claire F. Verschraegen, Laurence W. Cole, Heather M. Greene, Carolyn Y. Muller, Clifford Qualls> ;The Journal of Reproductive Medicine. 2006 Oct 1
Join now to see all